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• HIV-host transcriptome studies focused on protein coding genes
• Majority of transcribed sequences originate from non-coding RNA
• lncRNA are largely unexplored in HIV infection / replication cycle
• lncRNAs can bind all biomolecules in the cell
• Found in human diseases, cell type/process specific
• Control transcription/translational processes in the cell 
Introduction
• Study HIV latency mechanisms and explore new treatment strategies
• Primary cell model for main reservoir of HIV: CD4 T cells: Planelles
• Focus on lncRNAs in HIV latency and cure research
Goal
• Ideal targets for viruses to quickly reshape gene expression
Methods
• Planelles Model: Primary HIV latency infection model in central 
memory CD4 T cells
• Differential expression (DE) between uninfected (UI) and latenty
infected (LI) cells  (total RNAseq, 4 biological replicates)
• Bioinformatic analysis
- mRNA pathway analysis
- lncRNA guilt-by-association analysis
• Flow cytometry readout latently infected cells (4 replicates) of p24 HIV 
antigen after cell stimulation with antiCD3/CD28 and CD4 sorting







Overview Differential Expression 7SLRNA as potential new target
• p53 pathway enriched in mRNAs (1)
FOXP3
B) 7SLRNA may function as p53 inhibitor and mimic HIV 
latency block by pifithrin-α
C) 7SLRNA is build into HIV particles
D) 7SLRNA interacts with APOBEC3G (A3G) and is 
necessary for antiviral A3G-response
p53 pathway overlap with mRNAs
Other pathways: proteasome, IL-7, cell cycle
• Heatmap representation of top 100 DE genes between 
UI and LI cells
• Biotype overview of 826 DE genes between UI and LI 
cells (FDR<0.05, adjusted p-value)
Pathway analysis mRNA/lncRNA
• Biological pathways for lncRNAs (guilt-by-association, enrichment 
scores with adjusted p-values < 0.05)
7SLRNA
A) 7SLRNA was upregulated in latently infected cells and 














• Knockdown validation of lncRNAs (locked nucleic acid based anti-sense oligonucleotides, Crispr Interference) in cell lines and CD4 T cells
• Overlap DE data of different primary T cell models of HIV latency (e.g. Spina model) to identify lncRNAs consistently dysregulated in latency
• RNA pulldown of lncRNA to identify interaction partners
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lncRNAs account for 115 DE genes in 
latently infected CD4 T cells
7SLRNA may be a new potential target in 
HIV latency cure strategies
• mRNAs show p53 pathway enrichment
• lncRNAs could be linked to biological 
pathways with possible roles in HIV latency
